A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors (Q34132883)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

title

A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

main subject

phase II clinical trial

0 references

oligodendrocyte

1 reference

based on heuristic

inferred from title

temozolomide

0 references

brain tumor

1 reference

based on heuristic

inferred from title

author

Nick Wong

series ordinal

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

author name string

Hui K Gan

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

Mark A Rosenthal

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

Anthony Dowling

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

Renate Kalnins

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

Elizabeth Algar

series ordinal

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

Angela Benson

series ordinal

7

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

Anne-Marie Woods

series ordinal

8

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

Lawrence Cher

series ordinal

9

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

publication date

8 February 2010

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

published in

Neuro-Oncology

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

volume

12

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

issue

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

page(s)

500-507

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

cites work

Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

5 July 2018

Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

5 July 2018

Oligodendroglioma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

5 July 2018

The 2007 WHO classification of tumours of the central nervous system

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

5 July 2018

Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

5 July 2018

Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

5 July 2018

1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

5 July 2018

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment [...]

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

5 July 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

5 July 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

5 July 2018

Temozolomide single-agent chemotherapy for newly diagnosed anaplastic oligodendroglioma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

28 October 2018

Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

28 October 2018

Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

28 October 2018

Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

28 October 2018

Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

28 October 2018

Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

28 October 2018

Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

28 October 2018

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2940620

retrieved

28 October 2018

Identifiers

DOI

10.1093/NEUONC/NOP065

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

PMC publication ID

2940620

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

PubMed publication ID

20406900

1 reference

stated in

Europe PubMed Central

PMC publication ID

2940620

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20406900%20AND%20SRC:MED&resulttype=core&format=json

retrieved

31 January 2020

ResearchGate publication ID

43226835

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34132883&oldid=1945633750"